Missed our session with Dr. Thomas Coates on Sickle Cell Disease and Gene Therapy?
The full recording is now available on our YouTube channel!
➡️Watch the full session: youtu.be/TDNCgKR3p18?...
#GeneTherapy #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases
🧬The second question of the day focuses on how patient-reported outcomes reflect clinical benefit after Casgevy therapy.
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders
Additional results from the Exa-cel study.
Focus: CLIMB SCD-121 Trial
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy @ash.hematology.org @asgct.bsky.social @genesndiseases.bsky.social @bsochaem.bsky.social @ash.edu.hematology.org
Our session with Dr. Thomas Coates is in 2 weeks!
Don’t miss this opportunity to hear from a top expert in the field!
🔗Register now:
hemehub.org/live-events
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine
Further results from the Exa-cel study.
Focus: CLIMB SCD-121 Trial
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders #StemCellTherapy #HematopoieticStemCells
🩸 Today’s question addresses long-term safety considerations for patients treated with Lyfgenia, focusing on which risks require ongoing surveillance.
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials
Additional facts about the Exa-cel (Exagamglogene Autotemcel, Casgevy) Study
Focus: CLIMB SCD-121 Trial
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders
Facts about the Exa-cel (Exagamglogene Autotemcel, Casgevy) Study
Focus: CLIMB SCD-121 Trial
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders #StemCellTherapy
#haematology #Sicklecelldisease #sicklecellgenetherapy #genetherapy #geneeditingtherapy #Casgevy #Exacel @vertexpharma.bsky.social #NHS #haemoglobin #clinicaltrials #functionalcure @AmandaPritchard #geneeditingtool #Crispr #editedstemcells #NHSEngland #clinicaltrials
www.bbc.co.uk/news/article...